Rani Therapeutics (RANI) Insider Trading & Ownership → One trade. One ticker. One week. (From Wealthpin Pro) (Ad) Free RANI Stock Alerts $6.67 -0.40 (-5.66%) (As of 04/22/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Rani Therapeutics (NASDAQ:RANI) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage50.02%Number OfInsiders Buying(Last 12 Months)3Amount OfInsider Buying(Last 12 Months)$147,388.73Number OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$10.58 M Get RANI Insider Trade Alerts Want to know when executives and insiders are buying or selling Rani Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address RANI Insider Buying and Selling by Quarter Ad WealthPressThe system that called 2023’s top 7 stocks is at it again…Look 2023 kind of sucked from a trading standpoint… Despite the market finishing 24% higher…. Just seven stocks did all of the work… Unless you were holding or actively trading those 7 stocks, your trading year probably wasn’t as fruitful as you had hoped… According to my research, my new trading system would have spotted all seven of the “Magnificent stocks” MONTHS before they reached the highs they are trading at today.Just follow this link here! Rani Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/6/2023Talat ImranCEOBuy10,000$2.27$22,700.00 12/4/2023Talat ImranCEOBuy5,000$2.57$12,850.00 11/29/2023Talat ImranCEOBuy20,000$2.05$41,000.00 11/24/2023Cortes Isidoro Alfonso QuirogaMajor ShareholderSell5,265,165$2.01$10,582,981.65 11/16/2023Maulik NanavatyDirectorBuy500$1.98$990.00 5/11/2023South Cone Investments LimitedMajor ShareholderBuy2,610$3.87$10,100.70 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 5/8/2023South Cone Investments LimitedMajor ShareholderBuy4,420$4.46$19,713.20 5/3/2023South Cone Investments LimitedMajor ShareholderBuy2,040$4.81$9,812.40 4/28/2023South Cone Investments LimitedMajor ShareholderBuy2,173$4.71$10,234.83 4/24/2023South Cone Investments LimitedMajor ShareholderBuy4,280$4.67$19,987.60 (Data available from 1/1/2013 forward) RANI Insider Trading Activity - Frequently Asked Questions Who is on Rani Therapeutics's Insider Roster? The list of insiders at Rani Therapeutics includes Cortes Isidoro Alfonso Quiroga, Maulik Nanavaty, Mir A Imran, South Cone Investments Limited, and Talat Imran. Learn more on insiders at RANI. What percentage of Rani Therapeutics stock is owned by insiders? 50.02% of Rani Therapeutics stock is owned by insiders. Learn more on RANI's insider holdings. Which Rani Therapeutics insiders have been buying company stock? The following insiders have purchased RANI shares in the last 24 months: Cortes Isidoro Alfonso Quiroga ($259,948.60), Maulik Nanavaty ($990.00), South Cone Investments Limited ($1,293,643.82), and Talat Imran ($76,550.00). How much insider buying is happening at Rani Therapeutics? Insiders have purchased a total of 274,627 RANI shares in the last 24 months for a total of $1,631,132.42 bought. Which Rani Therapeutics insiders have been selling company stock? The following insiders have sold RANI shares in the last 24 months: Cortes Isidoro Alfonso Quiroga ($10,582,981.65), and Mir A Imran ($853,881.28). How much insider selling is happening at Rani Therapeutics? Insiders have sold a total of 5,345,417 Rani Therapeutics shares in the last 24 months for a total of $11,436,862.93 sold. More Insider Trading Tools from MarketBeat Related Companies: URGN Insider Selling PGEN Insider Selling VTYX Insider Selling NATR Insider Selling ATAI Insider Selling NLTX Insider Selling EPIX Insider Selling ESPR Insider Selling ANRO Insider Selling ENTA Insider Selling Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: The 5 Stocks Most Sold By Insiders This Year3 Cheap Stocks Insiders are Buying: Investors Should Avoid 1The 5 Hottest CEO Stock Purchases So Far This Year3 Cheap Stocks that Insiders Bought in Q1Michael Burry Picked a Winner With GEN Restaurant Group This page (NASDAQ:RANI) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingHealthcare Takes A Big Step Forward With The Help Of AIThe Bull Reporttop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap Profits[Shocking] Elon Musk’s Plan To End BanksCrypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressThe #1 Crypto for 2024InvestorPlaceGreat Crypto BullWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rani Therapeutics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
